GRAACC
GRAACC is a nonprofit pediatric oncology hospital in São Paulo, Brazil, founded in 1991, that treats children and adolescents (0–19) with cancer from across Brazil and Latin America. It delivers chemotherapy, radiotherapy, surgery, and bone marrow transplants, funded via health insurance reimbursements, the SUS public system, and charitable donations.
- Company typePrivate
- Founded1991
- HeadquartersSão Paulo, Brazil
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What GRAACC does
GRAACC (Grupo de Apoio ao Adolescente e a Criança com Câncer) is a nonprofit specialized pediatric oncology hospital founded in 1991 in São Paulo, Brazil, treating children and adolescents (0–19 years) with cancer from all 27 Brazilian states and Latin America. The hospital delivers comprehensive multidisciplinary cancer care including chemotherapy, radiotherapy, surgery, bone marrow transplantation, diagnostic imaging, genetics, and 24/7 emergency services, supported by advanced technology such as an Elekta Synergy Full linear accelerator for IMRT/IGRT/VMAT radiotherapy, a Latin America-first intraoperative MRI-equipped neuro-oncology surgery center, intra-arterial chemotherapy for retinoblastoma, a stem cell cryopreservation facility, and a 10-bed pediatric ICU. It is the first pediatric oncology center in Latin America to receive Joint Commission International (JCI) accreditation (2017, reaccredited 2023) and is habilitated by Brazil's Ministry of Health as a High Complexity Oncology Unit (UNACON) since 2012.
The hospital achieves an ~80% average cure rate (up from 70% in 2016), with cumulative milestones of 1,000+ bone marrow transplants (2022) and 1,000+ intra-arterial chemotherapy applications for retinoblastoma (2020). GRAACC's business model combines three revenue streams: reimbursements from over 30 health insurance operators (Amil, Bradesco, Sul América, Notre Dame Intermédica, Porto Seguro, Prevent Senior) where GRAACC is a credenciado provider; SUS public healthcare system reimbursements as an UNACON; and a diversified charitable donation engine including individual monthly donors, McDonald's McDia Feliz campaign, Ronald McDonald House partnership, Lei Rouanet / FUMCAD / Nota Fiscal Paulista incentive-law donations, corporate marketing partnerships (Bettanin's Golden Movement, U2 fan club, Shopee, Electrolux, Eurofarma, Microsoft, Google), fundraising events (gala, runs, concerts), and an online store and thrift bazaar. Distribution combines direct hospital care at the Vila Clementino facility with channel-based patient referrals through insurance networks and inter-state/international case routing.
GRAACC firmographics
Firmographics- Name
- GRAACC
- Legal name
- Grupo de Apoio ao Adolescente e a Criança com C GRAACC
- Website
- https://graacc.org.br
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- GRAACC is a nonprofit pediatric oncology hospital in São Paulo, Brazil, founded in 1991, that treats children and adolescents (0–19) with cancer from across Brazil and Latin America. It delivers chemotherapy, radiotherapy, surgery, and bone marrow transplants, funded via health insurance reimbursements, the SUS public system, and charitable donations.
- Ownership category
- akta.pro rank
GRAACC industry classification
Industry- Product category
- Pediatric Oncology Hospital
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where GRAACC is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices4 records
Markets served
GRAACC business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain
Revenue model
- Health Insurance Reimbursements (Convenios): GRAACC provides services to patients covered by numerous health insurance plans. The hospital is credenciado (network provider) for over 30 health insurance operators including major players like Amil, Bradesco, Sul América, and Notre Dame Intermédica, receiving reimbursement for services rendered.
- Government Health System (SUS): In 2012, GRAACC was habilitated by the Ministry of Health as a High Complexity Oncology Unit exclusive for pediatric care, enabling public healthcare system funding and reimbursements.
- Donations and Charitable Contributions: GRAACC relies heavily on donations from individuals, corporations, and events. Multiple donation mechanisms exist: monthly donors, one-time donations, corporate partnerships, event fundraising (runs, galas, concerts), and incentive laws (Lei Rouanet, Nota Fiscal Paulista).
- Social Marketing and Corporate Partnerships: Corporate partners run campaigns allocating percentage of sales or specific donations to GRAACC, including McDonald's McDia Feliz, U2 fan club campaigns, restaurant partnerships, and retail promotions.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
GRAACC product offering
Product offeringCore offering
GRAACC operates a specialized pediatric oncology hospital providing comprehensive cancer diagnosis and treatment for children and adolescents (0-19 years). Core offerings include chemotherapy, intensity-modulated radiotherapy, neurosurgery with intraoperative MRI, bone marrow transplantation, retinoblastoma treatment with intra-arterial chemotherapy, diagnostic imaging, genetic testing, and 24/7 emergency care. The hospital also provides humanization support services including a playroom, family accommodation, rehabilitation center, and mobile school for continuity of education during treatment.
Product overview
GRAACC is a specialized pediatric oncology hospital offering comprehensive cancer treatment through an integrated platform of medical services and support units. The core treatment services include neurosurgery with intraoperative MRI, intensity-modulated radiotherapy, diagnostic imaging, bone marrow transplantation, chemotherapy (Quimioteca), and emergency care. Specialized units cover retinoblastoma, genetics, and cryopreservation of stem cells. Support services include a playroom (Brinquedoteca), Ronald McDonald Family Space, rehabilitation center (Reabiliteca), and mobile school (Escola Móvel) for continuity of education during treatment. The hospital holds JCI international accreditation and serves patients from all Brazilian states and Latin America.
Differentiator
Problem solved
Functional benefit
Products and services
- Centro de Neurocirurgia Oncológica com Ressonância Magnética (Neuro-Oncology Surgery Center with MRI) First pediatric oncology neurosurgery center in Latin America with neuronavigator-equipped surgical suite, providing safer and less invasive brain tumor surgeries for children and adolescents. Includes microscope, ultrasonic aspirator, optical and magnetic neuronavigation system, and MRI-compatible cranium fixation system for intraoperative imaging guidance.
- Radioterapia de Intensidade Modulada (Intensity-Modulated Radiotherapy) Radiation therapy service equipped with latest-generation technology including Elekta Synergy Full linear accelerator, IMRT (Intensity-Modulated Radiotherapy), IGRT (Image-Guided Radiotherapy), VMAT (Volumetric Modulated Arc Therapy), and image-guided treatment verification for precise tumor targeting with reduced side effects to healthy tissues.
- Centro de Diagnóstico por Imagem (Diagnostic Imaging Center) Diagnostic imaging center with two MRI rooms, 64-channel multi-slice CT scanner, ultrasound with Doppler, and digital X-ray for precise tumor staging and diagnosis in pediatric oncology patients.
- Unidade de Retinoblastoma (Retinoblastoma Unit) Specialized unit for eye cancer treatment using innovative intra-arterial chemotherapy, along with cryotherapy, enucleation, laser therapy, intravenous and intravitreal chemotherapy techniques to preserve vision and ocular globe in pediatric retinoblastoma patients.
- Centro de Transplante de Medula Óssea (Bone Marrow Transplant Center) Bone marrow transplant center offering autologous, allogeneic, and haploidentical transplants for leukemias, lymphomas, solid tumors, and bone marrow aplasia, with dedicated inpatient rooms. Has performed over 1,000 bone marrow transplants since program inception.
- Pronto Atendimento (Emergency Care) 24-hour emergency and urgent care service with eight observation beds and one emergency bed for pediatric oncology patients undergoing treatment at the hospital.
- Hemoterapia: Unidade de Coleta e Transfusão (Hemotherapy: Collection and Transfusion Unit) Blood bank and transfusion service storing blood and derivatives, performing pre-transfusion immunohematological tests, managing hemocomponent utilization, and conducting apheresis procedures for pediatric oncology patients.
- UTI Pediátrica (Pediatric ICU) Pediatric intensive care unit with 10 beds, continuous hemodialysis machine, cardiac monitors, pulse oximetry, mechanical ventilation, physiological monitoring center, HEPA-filter isolation beds, intracranial pressure monitors, and gasometry equipment for critically ill pediatric oncology patients.
- Centro Cirúrgico (Surgical Center) Surgical center for high-complexity pediatric oncological surgeries including orthopedic procedures with endoprostheses, abdominal and thoracic surgeries, neurosurgeries, bone marrow collection, and central venous catheter placement.
- Laboratório de Genética (Genetics Laboratory) Genetics laboratory offering cytogenetics and molecular genetics tests for cancer diagnosis, prognostic factors, therapy monitoring, and an oncogenetics outpatient clinic for patients with family history of cancer.
- Centro de Criopreservação de Células Tronco Hematopoiéticas (Hematopoietic Stem Cell Cryopreservation Center) Stem cell cryopreservation center with capacity to process and store all types of hematopoietic progenitor stem cells for transplant procedures.
- Quimioteca (Humanized Chemotherapy) Humanized chemotherapy administration space with colorful environments, volunteer activities, story telling, games, therapeutic activities, and music for patient comfort during treatment.
Quantifiable outcome
- 80% average cure rate for childhood and adolescent cancer patients
- +2 more outcomes
Companies that use GRAACC
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
GRAACC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
GRAACC partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, flagship and minor.
- Universidade Federal de São Paulo (UNIFESP)coreTechnical-scientific partnership established in 1998 with UNIFESP's Paulista Medical School for medical education, research, and clinical collaboration in pediatric oncology. The partnership provides academic rigor and continuous medical education for GRAACC's healthcare professionals.
- Instituto Ronald McDonaldcorePartnership for the Casa Ronald McDonald São Paulo-Moema, a support facility providing accommodation for families of patients receiving treatment at GRAACC. The facility offers comfortable sofas, kitchen, bathrooms with showers, lockers, and rest spaces for families.
- McDonald's Brazil (McDia Feliz)flagshipAnnual McDia Feliz campaign where McDonald's sells special tickets and products, with proceeds donated to GRAACC. One of GRAACC's longest-running corporate partnerships for fundraising.
- ElectroluxminorCorporate partner supporting GRAACC through donations and marketing campaigns.
- EurofarmaminorPharmaceutical company partner supporting GRAACC through donations and marketing campaigns.
- BradescominorBanking and insurance company partner supporting GRAACC through donations and marketing campaigns.
- MicrosoftminorTechnology company partner supporting GRAACC through donations and marketing campaigns.
- GoogleminorTechnology company partner supporting GRAACC through donations and marketing campaigns.
- U2 Fan Club (ULTRAVIOLET-U2)flagshipFan club has conducted annual fundraising campaigns for GRAACC for over 20 consecutive years, mobilizing international fan community for donations.
- Bettanin (Movimento Dourado)flagshipAnnual 'Golden Movement' campaign during Childhood Cancer Awareness Month (September/Golden September) to raise awareness and funds for early diagnosis of childhood cancer.
- Shopee BrazilminorE-commerce platform partner conducting donation campaigns and offering discount coupons to customers who donate to GRAACC.
- Target Estratégia em ComunicaçãominorCommunication agency providing press relations and media strategy services for GRAACC.
- Over 30 Health Insurance OperatorscoreExtensive network of health insurance providers including Amil, Bradesco Saúde, Sul América, Notre Dame Intermédica, Porto Seguro, Prevent Senior, and many others where GRAACC is a credenciado (network provider) for insured pediatric oncology patients.
Scale indicators5 records
Recent moves12 records
Expansion highlights5 records
GRAACC competitors and assessment
Company assessmentDirect peers
- Hospital Infantil Sabará: São Paulo-based pediatric hospital with significant specialty and oncological care. Comparable as a São Paulo pediatric hospital delivering complex pediatric care with associated partnerships and accreditations.
- Hospital Pequeno Príncipe: Major pediatric hospital in Curitiba that also runs high-complexity pediatric oncology and BMT programs. Comparable because it is one of Brazil's flagship pediatric specialty hospitals treating complex childhood conditions including cancer, serving a similar patient population across multiple states.
- St. Jude Children's Research Hospital: Globally recognized pediatric oncology research and treatment hospital. Comparable as a mission-driven, high-volume pediatric oncology center publishing cure-rate outcomes and conducting research, providing a global benchmark for GRAACC's mission and operating model.
Broad incumbents
- A.C. Camargo Cancer Center: Major São Paulo-based oncology hospital and research center. Comparable as a high-complexity oncology provider in the same metropolitan market with research output and multidisciplinary cancer care, though not exclusively pediatric.
- Hospital de Amor (formerly Hospital de Câncer de Barretos - pediatric unit): Brazilian hospital network with a dedicated pediatric oncology unit and high treatment volumes, including BMT. Comparable as a high-volume Brazilian pediatric oncology provider with similar SUS and convenio reimbursement mix.
- Hospital Israelita Albert Einstein: Large Brazilian hospital system with a JCI-accredited oncology program that includes pediatric oncology. Comparable as a high-accreditation tertiary provider in São Paulo with advanced radiotherapy, BMT, and surgical capabilities, though broader in scope.
- Hospital de Câncer de Barretos: Large Brazilian oncology center treating high volumes of cancer patients including a meaningful pediatric share. Comparable as a major Brazilian oncology referral hospital with high-complexity treatment capabilities, though its adult caseload dominates.
- Children's Hospital of Philadelphia (CHOP): Top-ranked U.S. pediatric hospital with a leading pediatric oncology program and research institute. Comparable as a high-accreditation, research-intensive pediatric oncology provider, though operating at much larger scale in a different payer environment.
- Instituto Nacional de Câncer (INCA): Brazilian federal cancer reference hospital and public oncology authority. Comparable as a Brazilian oncology reference institution treating complex cases via SUS and serving as a national oncology hub, though with a broader (adult-inclusive) mandate.
- Hospital Sírio-Libanês: São Paulo tertiary hospital with comprehensive oncology services including pediatric cases. Comparable as a JCI-accredited Brazilian tertiary provider competing for the same high-complexity oncology referral pipeline in São Paulo.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
GRAACC social profiles
Digital presenceGRAACC financial estimates
Financial estimateRevenue estimate
Valuation estimate
GRAACC leadership team
Management profileNumber of profiles
GRAACC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GRAACC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GRAACC
What does GRAACC do?
GRAACC operates a specialized pediatric oncology hospital providing comprehensive cancer diagnosis and treatment for children and adolescents (0-19 years). Core offerings include chemotherapy, intensity-modulated radiotherapy, neurosurgery with intraoperative MRI, bone marrow transplantation, retinoblastoma treatment with intra-arterial chemotherapy, diagnostic imaging, genetic testing, and 24/7 emergency care. The hospital also provides humanization support services including a playroom, family accommodation, rehabilitation center, and mobile school for continuity of education during treatment.
Is GRAACC a public or private company?
GRAACC is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was GRAACC founded?
GRAACC was founded in 1991. It employs 501 to 1,000 people.
Where is GRAACC based?
GRAACC is headquartered in São Paulo, Brazil, in the Latin America region.
How does GRAACC make money?
Four revenue lines are on record. Health Insurance Reimbursements (Convenios) is the primary driver. The others are government Health System (SUS), donations and Charitable Contributions and social Marketing and Corporate Partnerships.
Who are GRAACC's main competitors?
Direct peers on record are Hospital Infantil Sabará, Hospital Pequeno Príncipe and St. Jude Children's Research Hospital. Broad incumbents are A.C. Camargo Cancer Center, Hospital de Amor (formerly Hospital de Câncer de Barretos - pediatric unit), Hospital Israelita Albert Einstein, Hospital de Câncer de Barretos, Children's Hospital of Philadelphia (CHOP), Instituto Nacional de Câncer (INCA) and Hospital Sírio-Libanês.
Does GRAACC have an API?
No public API is recorded for GRAACC.
What industry is GRAACC in?
GRAACC's product category is Pediatric Oncology Hospital. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62231 and its SIC code is 8062.